Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Debbie Wong who wrote (2626)	7/17/1999 2:16:00 AM
From: John Romeo	Respond to of 4676

I wouldn't get overly excited about the 7/24 Roadshow. They have been to many and have little to no effect on subsequent stock price.

To: Debbie Wong who wrote (2626)	7/28/1999 4:58:00 PM
From: tom jones	Read Replies (1) \| Respond to of 4676

To all: I think this presentation by Isis is worth your time to hear: biz.yahoo.com Don't know how long it will be available. Isis will close the 2302 Crohn's trial in July. May hear news of this in their July 31 presentation. 2302 for Crohn's timetable; results by year end or January 2000, New Drug Application first quarter 2000 and market in fourth quarter 2000. Results for 3 phase II cancer drugs in January 2000. Will start 3 phase I trials this year for Hepatitis C, 2302 topical Psoriasis and 2302 for Ulcerative Colitis. Should announce new partnerships for a new drug and one for drug manufacturing. Comments? Tom